BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 11306514)

  • 1. Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma.
    Kunz M; Ibrahim S; Koczan D; Thiesen HJ; Köhler HJ; Acker T; Plate KH; Ludwig S; Rapp UR; Bröcker EB; van Muijen GN; Flory E; Gross G
    Cell Growth Differ; 2001 Mar; 12(3):137-45. PubMed ID: 11306514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
    Ferrer I; Friguls B; Dalfó E; Planas AM
    Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
    Mansouri A; Ridgway LD; Korapati AL; Zhang Q; Tian L; Wang Y; Siddik ZH; Mills GB; Claret FX
    J Biol Chem; 2003 May; 278(21):19245-56. PubMed ID: 12637505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
    Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
    Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.
    Atfi A; Prunier C; Mazars A; Défachelles AS; Cayre Y; Gespach C; Bourgeade MF
    Oncogene; 1999 Jul; 18(26):3878-85. PubMed ID: 10445851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation mechanism and physiological roles of stress-activated protein kinase/c-Jun NH2-terminal kinase in mammalian cells.
    Nishina H; Nakagawa K; Azuma N; Katada T
    J Biol Regul Homeost Agents; 2003; 17(4):295-302. PubMed ID: 15065757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ; Kim BC; Kim SJ; Choi KS
    Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity.
    Laderoute KR; Mendonca HL; Calaoagan JM; Knapp AM; Giaccia AJ; Stork PJ
    J Biol Chem; 1999 Apr; 274(18):12890-7. PubMed ID: 10212278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells.
    Soh Y; Jeong KS; Lee IJ; Bae MA; Kim YC; Song BJ
    Mol Pharmacol; 2000 Sep; 58(3):535-41. PubMed ID: 10953046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells.
    Guan Z; Buckman SY; Springer LD; Morrison AR
    J Biol Chem; 1999 Dec; 274(51):36200-6. PubMed ID: 10593906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet radiation-induced apoptosis is mediated by Daxx.
    Wu S; Loke HN; Rehemtulla A
    Neoplasia; 2002; 4(6):486-92. PubMed ID: 12407442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Jun NH2-terminal kinase-dependent Fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
    Prostate; 2003 Jun; 55(4):265-80. PubMed ID: 12712406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK.
    Swantek JL; Cobb MH; Geppert TD
    Mol Cell Biol; 1997 Nov; 17(11):6274-82. PubMed ID: 9343388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
    Mhaidat NM; Zhang XD; Jiang CC; Hersey P
    Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival.
    Wang X; Martindale JL; Liu Y; Holbrook NJ
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):291-300. PubMed ID: 9657968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells.
    Su JL; Lin MT; Hong CC; Chang CC; Shiah SG; Wu CW; Chen ST; Chau YP; Kuo ML
    Carcinogenesis; 2005 Jan; 26(1):1-10. PubMed ID: 15217905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
    Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
    Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.